COSMOS Pharmaceutical Corporation
3349.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥699,998 | ¥502,778 | ¥525,083 | ¥483,108 |
| - Cash | ¥57,038 | ¥52,301 | ¥45,928 | ¥37,362 |
| + Debt | ¥49,957 | ¥34,063 | ¥18,201 | ¥9,413 |
| Enterprise Value | ¥692,917 | ¥484,540 | ¥497,356 | ¥455,159 |
| Revenue | ¥1,011,390 | ¥964,989 | ¥827,697 | ¥755,414 |
| % Growth | 4.8% | 16.6% | 9.6% | – |
| Gross Profit | ¥213,281 | ¥188,306 | ¥168,718 | ¥151,448 |
| % Margin | 21.1% | 19.5% | 20.4% | 20% |
| EBITDA | ¥64,855 | ¥53,744 | ¥50,192 | ¥48,210 |
| % Margin | 6.4% | 5.6% | 6.1% | 6.4% |
| Net Income | ¥30,978 | ¥24,454 | ¥23,797 | ¥23,155 |
| % Margin | 3.1% | 2.5% | 2.9% | 3.1% |
| EPS Diluted | 390.85 | 308.61 | 300.48 | 292.37 |
| % Growth | 26.6% | 2.7% | 2.8% | – |
| Operating Cash Flow | ¥52,467 | ¥52,467 | ¥55,175 | ¥54,434 |
| Capital Expenditures | -¥53,326 | -¥53,326 | -¥55,810 | -¥46,636 |
| Free Cash Flow | -¥859 | -¥859 | -¥635 | ¥7,798 |